Recent Finacing
Recent Raise
InFlectis BioScience (Nantes, France) discovers and develops small-molecule therapeutics for protein‑misfolding diseases, advancing IFB‑088 into human clinical studies and selecting a PPP1R15A inhibitor candidate.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
